Trial Profile
Allogeneic Haematopoietic Stem Cell Transplantation From a Matched Donor in Patients With Chronic Myeloid Leukemia Failing to Gain Normal Hemopoiesis Under TKIs Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bosutinib (Primary)
- Indications Myeloid leukaemia
- Focus Therapeutic Use
- 03 Nov 2020 Status changed from recruiting to completed.
- 06 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Jan 2019.
- 06 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jan 2019.